Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase I study of C21

Trial Profile

A Phase I study of C21

Planning
Phase of Trial: Phase I

Latest Information Update: 11 Jul 2018

At a glance

  • Drugs C-21 (Primary)
  • Indications Idiopathic pulmonary fibrosis
  • Focus Adverse reactions
  • Most Recent Events

    • 11 Jul 2018 New trial record
    • 03 Jul 2018 INIM is currently working on optimization of formulation and other preparatory activities in order to initiate a Phase I clinical trial in 2019, as reported in a Vicore Pharma media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top